Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Fumihiko Kanzawa"'
Publikováno v:
Lung Cancer. 40:325-332
Among numerous clinical regimens of combination chemotherapy, synergy has been observed to be particularly marked with combinations containing cisplatin (CDDP). However, the clinical use of CDDP has sometimes been limited by acquired resistance. The
Autor:
Shoji Tsukiyama, Fumiaki Koizumi, Yutaka Ueda, Kazuto Nishio, Tomohide Tamura, Yasuhiro Koh, Fumiko Taguchi, Nagahiro Saijo, Fumihiko Kanzawa
Publikováno v:
International Journal of Cancer. 108:464-472
Epidermal growth factor receptor [EGFR (HER1, erbB1)] is a receptor with associated tyrosine kinase activity, and is expressed in colorectal cancers and many other solid tumors. We examined the effect of the selective EGFR tyrosine kinase inhibitor (
Autor:
Fumihiko Kanzawa, Yoshiko Kawamura-Akiyama, Nagahiro Saijo, Kazuto Nishio, Tomohide Tamura, H Kusaba
Publikováno v:
Lung Cancer. 38:43-50
ZD0473 is a new generation platinum agent that, in preclinical studies, shows evidence of an extended spectrum of anti-tumor activity and overcomes platinum resistance mechanisms. The drug contains a bulky methylpyridine ligand at its platinum center
Autor:
Hirokazu Kurokawa, Toshihiro Suzuki, Nagahiro Saijo, Hisao Fukumoto, Jitsuo Usuda, Tomoyuki Ishida, Kazuya Fukuoka, Yasuo Iwamoto, Akira Tomonari, Kazuto Nishio, Hiroshi Kimura, Fumihiko Kanzawa, Hitoshi Arioka
Publikováno v:
Cancer Chemotherapy and Pharmacology. 49:385-390
Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization. The aims of this study were to demonstrate vinorelbine-induced radiosensitization of human small cell lung cancer (SCLC) SB
Autor:
Takashi Sugimura, Takashi Kanazawa, Noriaki Tanaka, Kotaro Koyama, Fumihiko Kanzawa, Keiji Wakabayashi, Masahiko Watanabe, Yuko Matsushima-Hibiya
Publikováno v:
Proceedings of the Japan Academy, Series B. 78:305-308
Pierisin-1 is a 98kDa protein known to induce apoptosis in various human carcinoma cell lines with a very wide range of IC50 values. Among those, the cervical carcinoma HeLa cells are the most sensitive, showing IC50 value of 0.043ng/ml. In the prese
Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells
Autor:
Akira Tomonari, Tomoyuki Ishida, Fumihiko Kanzawa, Jitsuo Usuda, Hirokazu Kurokawa, Hitoshi Arioka, Toshihiro Suzuki, Hisao Fukumoto, Kazuya Fukuoka, Yasuo Iwamoto, Kazuto Nishio, Nagahiro Saijo
Publikováno v:
Lung Cancer. 34:451-460
Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization. The aims of this study were to demonstrate radiosensitization produced by vinorelbine in human non-small cell lung cancer (
Autor:
Nagahiro Saijo, Takashi Nakamura, Tomohide Tamura, Yasuhiro Koh, Fumihiko Kanzawa, Kazuto Nishio
Publikováno v:
Cancer. 91:1494-1499
BACKGROUND Oncoprotein 18 (op18) was first isolated as a molecule overexpressed in several malignant cells, suggesting a function of op18 in malignant processes, such as differentiation in hematologic malignancies, op18 also was found to enhance micr
Autor:
Nagahiro Saijo, Toshihiko Sunami, Jyunichi Yoshikawa, Kazuya Fukuoka, Kazuto Nishio, Shinzo Kudoh, Fumihiko Kanzawa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 43:394-401
Purpose: TAS-103 [6-((2-(dimethylamino) ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one dihydrochloride] is a newly synthesized dual inhibitor of topoisomerase I and II. Since anticancer drugs are used in combination with other drugs for effect
Autor:
Kazuto Nishio, Nagahiro Saijo, Takehiko Kunimoto, Fumihiko Kanzawa, Minoru Fukuda, Kazuya Fukuoka
Publikováno v:
International Journal of Cancer. 71:311-319
Although the combination of cisplatin and etoposide has been used as standard therapy for small-cell lung cancer, it is difficult to demonstrate combination effects between cisplatin and etoposide in vitro. We therefore adopted a 3-dimensional (3-D)
Autor:
Hirokazu Kurokawa, K. Bojanowski, H Fukumoto, Minoru Fukuda, Nagahiro Saijo, K Fukuoka, Kazuto Nishio, Y Nomoto, Fumihiko Kanzawa, Takanori Ishida
Publikováno v:
British Journal of Cancer
Drug resistance is one of the problems severely limiting chemotherapy in cancer patients. Thus, it is very important to develop new drugs that are effective against drug-resistant tumour cells. The novel anti-tumour agent NK109 has been developed fro